Recent studies have showed that the complement abnormalities, such as reduced C3 levels, reflecting activation of complement alternative pathway, are found only in a subset of patients, and are not necessary to make the diagnosis of atypical HUS [20,22]. The gene discussed is C3; the disease is hemolytic-uremic syndrome.